Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells

This publication has 38 references indexed in Scilit:

• Novel Effects of Azithromycin on Tight Junction Proteins in Human Airway Epithelia
  Antimicrobial Agents and Chemotherapy, 2006
• Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach
  Antimicrobial Agents and Chemotherapy, 2006
• Increased NaCl-induced interleukin-8 production by human bronchial epithelial cells is enhanced by the ΔF508/W1282X mutation of the cystic fibrosis transmembrane conductance regulator gene
  Cytokine, 2006
• Long-Term Azithromycin Use for Treatment of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients
  The Journal of Heart and Lung Transplantation, 2005
• PHARMACOKINETICS OF AZITHROMYCIN IN LUNG TISSUE, BRONCHIAL WASHING, AND PLASMA IN PATIENTS GIVEN MULTIPLE ORAL DOSES OF 500 AND 1000 MG DAILY
  Pharmacological Research, 2002
• Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
  Thorax, 2002
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease
  European Respiratory Journal, 1999
• Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.
  Journal of Clinical Investigation, 1998
• Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice
  Gene Therapy, 1998